has reported Standalone financial results for the period ended June 30, 2024.
Financial Results (Q1 FY2025) - QoQ Comparison
The company has reported total income of Rs. 39.3517 crores during the period ended June 30, 2024 as compared to Rs. 43.0297 crores during the period ended March 31, 2024.
The company has posted net profit / (loss) of Rs. 13.2362 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs. 15.8856 crores for the period ended March 31, 2024.
The company has reported EPS of Rs. 1.82 for the period ended June 30, 2024 as compared to Rs. 2.19 for the period ended March 31, 2024.
Total Income | ₹ 39.3517 crs | ₹43.0297 crs | -8.55% |
Net Profit | ₹13.2362 crs | ₹15.8856 crs | -16.68% |
EPS | ₹1.82 | ₹2.19 | -16.89% |
Financial Results (Q1 FY2025) - YoY Comparison The company has reported total income of Rs. 39.3517 crores during the period ended June 30, 2024 as compared to Rs.50.6627 crores during the period ended June 30, 2023.
The company has posted net profit / (loss) of Rs.13.2362 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs.17.7216 crores for the period ended June 30, 2023.
The company has reported EPS of Rs.1.82 for the period ended June 30, 2024 as compared to Rs.2.44 for the period ended June 30, 2023.
Total Income | ₹ 39.3517 crs | ₹50.6627 crs | -22.33% |
Net Profit | ₹13.2362 crs | ₹17.7216 crs | -25.31% |
EPS | ₹1.82 | ₹2.44 | -25.41% |
Source : Equity Bulls
Keywords
GujaratThemisBiosyn
Q1FY25
FY2025
Q1FY2025
ResultUpdate